Literature DB >> 20563246

Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer.

Carl-Jørgen Arum1, Endre Anderssen, Trond Viset, Yosuke Kodama, Steinar Lundgren, Duan Chen, Chun-Mei Zhao.   

Abstract

Cancer cells can develop an attenuated immunogenicity and/or create an immunosuppressive microenvironment to prevent tumor eradication by host immune system, the so-called "cancer immunoediting" hypothesis. The aim of the present study was to find evidence for this hypothesis by using a rat orthotopic bladder cancer model. Fisher rats were inoculated with AY-27 cells (a Fisher rat bladder cancer cell line). Cultured cancer cells, rat and human bladder cancer tissues, and publicly available microarray data from human bladder cancer were analyzed by means of bioinformatics and morphology. Results showed that 12 of 24 differentially expressed pathways were concordant in connection to cell cycle and proliferation between rats and humans (both non-muscle-invasive and muscle-invasive tumors) and that 11 of the 24 pathways, including major histocompatibility complex, were related to host immunosurveillance with activations of T cells and natural killer cells in rats. The altered pathways and morphogenesis of this rat model corresponded more closely with those of human muscle-invasive rather than non-muscle-invasive tumors. A unique ultrastructure displaying microvillus-formed niches was found in small areas within the tumor of both rats and humans. These niches were interconnected with desmosomes between cancer cells and without infiltration of lymphocytes. The expression of E-cadherin, selectins, PGP9.5, vascular endothelial growth factor, caspase-3, CD133, Oct-4, nestin, CD3, and CD45RA was lower in the tumor than in the adjacent normal epithelium. We suggest that the microvillus-formed niche that harbors a few implanted cancer cells might be the compartment that prevents the tumor eradication by the host immune system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20563246      PMCID: PMC2887496          DOI: 10.1593/neo.91824

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  23 in total

Review 1.  Cancer despite immunosurveillance: immunoselection and immunosubversion.

Authors:  Laurence Zitvogel; Antoine Tesniere; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2006-09-15       Impact factor: 53.106

2.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

3.  The relationship between the spleen colony-forming cell and the haemopoietic stem cell.

Authors:  R Schofield
Journal:  Blood Cells       Date:  1978

4.  Gene expression profiling of chemically induced rat bladder tumors.

Authors:  Ruisheng Yao; Yijun Yi; Clinton J Grubbs; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

Review 5.  Cancer immunoediting from immune surveillance to immune escape.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe
Journal:  Immunology       Date:  2007-03-26       Impact factor: 7.397

6.  Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells.

Authors:  Hui Liu; Scott F Collins; Laura J Suggs
Journal:  Biomaterials       Date:  2006-07-24       Impact factor: 12.479

Review 7.  Normal stem cells and cancer stem cells: the niche matters.

Authors:  Linheng Li; William B Neaves
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 8.  Tumor immunoediting and immunosculpting pathways to cancer progression.

Authors:  Jennifer M Reiman; Maciej Kmieciak; Masoud H Manjili; Keith L Knutson
Journal:  Semin Cancer Biol       Date:  2007-06-26       Impact factor: 15.707

Review 9.  Breast tumor heterogeneity: cancer stem cells or clonal evolution?

Authors:  Lauren L Campbell; Kornelia Polyak
Journal:  Cell Cycle       Date:  2007-08-17       Impact factor: 4.534

Review 10.  Role of chemokines in tumor growth.

Authors:  Dayanidhi Raman; Paige J Baugher; Yee Mon Thu; Ann Richmond
Journal:  Cancer Lett       Date:  2007-07-12       Impact factor: 8.679

View more
  15 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

Review 2.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

4.  Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer.

Authors:  Yuanmei Chen; Xinyi Huang; Lin Chen; Guibin Weng; Zhengrong Huang; Yangfan Zhang; Tianya Xiao; Junqiang Chen; Kunshou Zhu; Yuanji Xu
Journal:  Mol Biotechnol       Date:  2022-07-03       Impact factor: 2.695

5.  Correlation between aryl hydrocarbon receptor and IL-17+ and Foxp3+ T-cell infiltration in bladder cancer.

Authors:  Soheila Fattahi; Monireh Karimi; Mahdi Ghatreh-Samani; Fatemeh Taheri; Hedayatollah Shirzad; Faramarz Mohammad Alibeigi; Maryam Anjomshoa; Nader Bagheri
Journal:  Int J Exp Pathol       Date:  2021-11-11       Impact factor: 1.925

6.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

Review 7.  IL-10 Signaling in the Tumor Microenvironment of Ovarian Cancer.

Authors:  Ramesh B Batchu; Oksana V Gruzdyn; Bala K Kolli; Rajesh Dachepalli; Prem S Umar; Sameer K Rai; Namrata Singh; Pavan S Tavva; Donald W Weaver; Scott A Gruber
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.

Authors:  Sin Mun Tham; Kee Hui Ng; Sim Hwee Pook; Kesavan Esuvaranathan; Ratha Mahendran
Journal:  Clin Dev Immunol       Date:  2011-10-13

Review 9.  Trial Watch: Peptide-based anticancer vaccines.

Authors:  Jonathan Pol; Norma Bloy; Aitziber Buqué; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-01-09       Impact factor: 8.110

10.  Characterization of glioma stem-like cells from human glioblastomas.

Authors:  Shun Yamamuro; Yutaka Okamoto; Emiko Sano; Yushi Ochiai; Akiyoshi Ogino; Takashi Ohta; Hiroyuki Hara; Takuya Ueda; Tomohiro Nakayama; Atsuo Yoshino; Yoichi Katayama
Journal:  Int J Oncol       Date:  2015-05-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.